[go: up one dir, main page]

AU4786701A - Compositions and methods for treating allergic and inflammatory conditions with cough - Google Patents

Compositions and methods for treating allergic and inflammatory conditions with cough

Info

Publication number
AU4786701A
AU4786701A AU4786701A AU4786701A AU4786701A AU 4786701 A AU4786701 A AU 4786701A AU 4786701 A AU4786701 A AU 4786701A AU 4786701 A AU4786701 A AU 4786701A AU 4786701 A AU4786701 A AU 4786701A
Authority
AU
Australia
Prior art keywords
cough
compositions
methods
inflammatory conditions
treating allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4786701A
Inventor
Sergio Rolando Ulloa Lugo
Jose De Jesus Villacampa Ramos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU4786701A publication Critical patent/AU4786701A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU4786701A 2000-03-30 2001-03-28 Compositions and methods for treating allergic and inflammatory conditions with cough Pending AU4786701A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19331000P 2000-03-30 2000-03-30
PCT/US2001/010019 WO2001074341A2 (en) 2000-03-30 2001-03-28 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant

Publications (1)

Publication Number Publication Date
AU4786701A true AU4786701A (en) 2001-10-15

Family

ID=22713096

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4786701A Pending AU4786701A (en) 2000-03-30 2001-03-28 Compositions and methods for treating allergic and inflammatory conditions with cough
AU2001247867A Ceased AU2001247867B2 (en) 2000-03-30 2001-03-28 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001247867A Ceased AU2001247867B2 (en) 2000-03-30 2001-03-28 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant

Country Status (13)

Country Link
CN (1) CN1422162A (en)
AR (1) AR025308A1 (en)
AU (2) AU4786701A (en)
BR (1) BR0003648A (en)
CO (1) CO5200779A1 (en)
CR (1) CR6232A (en)
NZ (1) NZ520826A (en)
PA (1) PA8500101A1 (en)
PE (1) PE20010576A1 (en)
SG (1) SG96611A1 (en)
TW (1) TWI243671B (en)
WO (1) WO2001074341A2 (en)
ZA (1) ZA200102605B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323662C (en) * 2004-06-18 2007-07-04 江苏恒瑞医药股份有限公司 Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof
WO2005123052A1 (en) * 2004-06-18 2005-12-29 Jiangsu Hengrui Medicine Co., Ltd. Drug composition containing ambroxol and erdosteine or acetylcysteine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
EP0719156A1 (en) * 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen

Also Published As

Publication number Publication date
BR0003648A (en) 2002-01-02
PE20010576A1 (en) 2001-05-08
ZA200102605B (en) 2001-10-03
CN1422162A (en) 2003-06-04
AR025308A1 (en) 2002-11-20
SG96611A1 (en) 2003-06-16
WO2001074341A3 (en) 2002-05-16
NZ520826A (en) 2004-07-30
CR6232A (en) 2008-12-01
CO5200779A1 (en) 2002-09-27
WO2001074341A2 (en) 2001-10-11
AU2001247867B2 (en) 2005-09-01
PA8500101A1 (en) 2002-09-17
TWI243671B (en) 2005-11-21

Similar Documents

Publication Publication Date Title
AP2006003708A0 (en) Methods and compositions for treating flavivirusesand pestiviruses
AU2001245437A1 (en) Lightweight methods and compositions for well treating
IL146904A0 (en) Gypsum compositions and related methods
AU2002360670A8 (en) Method and related composition employing nanostructures
DK1339292T3 (en) Composition and method
IL151781A0 (en) Methods and compositions for rna interference
AU2003220205A8 (en) Ethanol-diesel fuel composition and methods thereof
DE60229770D1 (en) FRICTION-REDUCING COMPOSITION AND METHOD
GB0126990D0 (en) Method and composition for improving fuel consumption
AU4163402A (en) Composition and method
AU4215901A (en) Methods and compositions for immunoregulation
AU2003297573A8 (en) Compositions and methods for treating transplants
AU2002230888A1 (en) Methods and compositions to treat conditions associated with neovascularization
EP1684771A4 (en) Composition and method
HUP0204048A3 (en) Use of desloratadine for treating allergic and inflammatory conditions
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
AU2001233259A1 (en) Use of desloratadine for treating allergic and inflammatory conditions
AU2002241911A1 (en) Methods to treat autoimmune and inflammatory conditions
AU2003296963A8 (en) Methods and compositions for treating and preventing ear infections
IL150963A0 (en) Method and compositions for treating an inflammatory disease
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
SG96611A1 (en) Compositions and methods for treating allergic and inflammatory conditions with cough
AU2001266648A1 (en) Kits and methods for optimizing the efficacy of chondroprotective compositions
ATE418339T1 (en) COMPOSITION AND METHOD
AU2001234685A1 (en) Methods and compositions for enhancing formyltetrahydropteroylpolyglutamate in plants